[Form 4] Organon & Co. Insider Trading Activity
Organon & Co. Chief Information Officer Rachel A. Stahler reported compensation-related stock activity.
Rhea-AI Filing Summary
Organon & Co. Chief Information Officer Rachel A. Stahler reported compensation-related stock activity. She was granted 183,639 restricted stock units (RSUs) on March 31, 2026, each representing a contingent right to one share of Organon common stock, vesting in three equal installments on March 31, 2027, 2028, and 2029.
On the same date, previously granted RSUs from March 31, 2023 and March 31, 2025 vested and were exercised into common shares. A total of 6,463 shares of common stock were withheld at a price of $5.70 per share to cover tax obligations. After these transactions, Stahler directly holds 116,105.292 shares of Organon common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
18,867 shares exercised/converted
Exercise
7 txns
Insider
Stahler Rachel A
Role
Chief Information Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 183,639 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 6,555 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 12,312 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,555 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,246 | $5.70 | $13K |
| Exercise | Common Stock | 12,312 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 4,217 | $5.70 | $24K |
Holdings After Transaction:
Restricted Stock Units — 208,264 contracts (Direct);
Common Stock — 116,105.292 shares (Direct)
Footnotes (5)
- F1. The price is the closing market price of Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
- F2. On March 31, 2026, the Reporting Person was granted 183,639 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
- F3. Each RSU represents a contingent right to receive one share of Organon common stock.
- F4. On March 31, 2023, the Reporting Person was granted 19,664 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026.
- F5. On March 31, 2025, the Reporting Person was granted 36,937 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028.
Key Figures
New RSU grant: 183,639 RSUs
RSU vesting schedule: 3 equal installments
RSUs exercised from 2023 grant: 6,555 units
+4 more
7 metrics
New RSU grant
183,639 RSUs
Granted March 31, 2026 to CIO Rachel A. Stahler
RSU vesting schedule
3 equal installments
Vesting on March 31, 2027, 2028, and 2029
RSUs exercised from 2023 grant
6,555 units
Restricted Stock Units converted into common stock on March 31, 2026
RSUs exercised from 2025 grant
12,312 units
Restricted Stock Units converted into common stock on March 31, 2026
Shares withheld for taxes
6,463 shares
Tax-withholding dispositions at $5.70 per share on March 31, 2026
Tax withholding price
$5.70 per share
Closing market price on March 30, 2026 used for RSU plan
Shares held after transactions
116,105.292 shares
Organon common stock directly owned by Stahler after March 31, 2026 activity
Key Terms
Restricted Stock Units, contingent right, tax-withholding disposition, derivative security, +1 more
5 terms
Restricted Stock Units financial
"The Reporting Person was granted 183,639 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each RSU represents a contingent right to receive one share of Organon common stock."
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
